期刊文献+

血清BAFF在系统性红斑狼疮的表达及临床意义 被引量:3

The Levels and Clinical Significance of B Cell Activating Factor in Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的:检测系统性红斑狼疮(SLE)患者血清B细胞活化因子(BAFF)表达水平,探讨BAFF与SLE病情活动指标及临床症状的关系。方法:采用酶联免疫吸附法(ELISA)检测80例SLE患者及60例健康对照血清BAFF水平;检测SLE患者抗双链DNA(ds-DNA)抗体等指标。结果:SLE组血清BAFF水平高于健康对照组(P<0.05),活动组BAFF水平高于非活动组及健康对照组(P<0.01)。SLE患者血清中BAFF水平与SLEDAI、血沉(ESR)呈正相关(P<0.01、P<0.05);与补体C3呈负相关(P<0.05)。抗ds-DNA抗体阳性SLE患者BAFF水平高于抗ds-DNA抗体阴性SLE患者(P<0.01)。结论:SLE患者BAFF水平升高,提示BAFF参与SLE发病,且与SLE病情活动指标相关。 Objective:To investigate the levels of B cell activating factor(BAFF) in systemic lupus erythematosus(SLE),and to analysis the correlation between BAFF and SLE disease activity index,clinical symptoms.Method:Serum BAFF levels were tested by Enzyme-linked immunosorbent assay(ELISA) in 80 patients with SLE and 60 healthy controls.Anti double stranded DNA(ds-DNA) antibodies in SLE patients were detected.Result:BAFF expression in SLE group was significantly higher than that in healthy control group(P〈0.05);BAFF expression in activity group higher than those in non activity group and health control group(P〈0.01).Serum BAFF expression was positively correlated with SLEDAI,ESR(P〈0.01,P〈0.05),and negatively correlated with C3(P〈0.05) in SLE patients.SLE patients with positive anti-ds DNA antibody had significantly higher expression of BAFF than that with negative anti-ds DNA antibody(P〈0.01).Conclusion:BAFF may be involved in SLE development,and may affected to SLE disease activity.
作者 黄惠娟 俞烜华 HUANG Huijuan;YU Xuanhua(People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine,Fuzhou 350004,China)
出处 《中外医学研究》 2018年第25期16-17,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 红斑狼疮 系统性 SLEDAI BAFF 抗DS-DNA抗体 BAFF Lupus erythematosus Systemic SLEDAI Anti-dsDNA antibody
  • 相关文献

参考文献12

二级参考文献99

  • 1苏茵,贾汝琳,栗占国.自身抗体联合检测在系统性红斑狼疮诊断中的意义[J].中华风湿病学杂志,2005,9(1):16-19. 被引量:16
  • 2杨卫平,付敏.ENA多肽抗体检测及临床意义[J].中原医刊,2005,32(23):17-18. 被引量:12
  • 3孟博,张志斌.抗核抗体在自身免疫性疾病的检测及应用[J].放射免疫学杂志,2006,19(1):78-79. 被引量:19
  • 4刘维.毒痹论[J].中国中医基础医学杂志,2007,13(1):15-15. 被引量:39
  • 5Weckerle CE, Franek BS,Kelly JA, et al. Network analysis ofassociations between serum interferon-alpha activity,autoantibodies, and clinical features in systemic lupuserythematosus[J]. Arthritis Rheum,2011,63(4) : 1044-1053.
  • 6Ramanujam M,Bethunaickan R,Huang W, et al. Selectiveblockade of BAFF for the prevention and treatment of systemiclupus erythematosus nephritis in NZM2410 mice[J]. ArthritisRheum, 2010,62(5) : 1457-1468.
  • 7Bombardier C. Gladman DD, Urowitz MB, et al. Derivation ofthe SLEDAI. A disease activity index for lupus patients. TheCommittee on Prognosis Studies in SLE[J], Arthritis Rheum,1992,35(6);630-640.
  • 8Stohl W, Metyas S,Tan SM, et al. B lymphocyte stimulatoroverexpression in patients with systemic lupus erythematosus:longitudinal observations[J]. Arthritis Rheum, 2003 , 48 ( 12):3475-3486.
  • 9Petri M,Stohl W, Chatham W, et al. Association of plasma Blymphocyte stimulator levels and disease activity in systemiclupus erythematosus[J], Arthritis Rheum. 2008,58(8) : 2453-2459.
  • 10ter Borg EJ, Horst G,Hummel EJ, et al. Measurement ofincreases in anti-double-stranded DNA antibody levels as apredictor of disease exacerbation in systemic lupuserythematosus. A long-term, prospective study [ J]. ArthritisRheum,1990,33(5) :634-643.

共引文献57

同被引文献32

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部